Home/Reveal Pharmaceuticals/Peter Caravan

PC

Peter Caravan

Co-Founder, Professor at Harvard Medical School / MGH

Reveal Pharmaceuticals

Therapeutic Areas

Oncology Fibrotic Diseases

Reveal Pharmaceuticals Pipeline

Drug	Indication	Phase
RVP-001	General Purpose MRI Contrast Enhancement	Phase 2
Fibrogenesis Imaging Agents	Diagnosis and Monitoring of Fibrotic Diseases	Pre-clinical

Leadership Team at Reveal Pharmaceuticals

Medical Professor, Strategic Advisor

Srinivasan Mukundan

Medical Director

Jennifer Woodfin

View full Reveal Pharmaceuticals profile